Therefore, CLDN3 expression was analyzed in more than 14,500 tumor tissue samples from 133 different tumor types and subtypes as well as 76 non-neoplastic tissue categories by IHC in a tissue microarray (TMA) format in this study. The gene discussed is CLDN3; the disease is neoplasm.